June 01, 2017
A combination of existing drugs can ease symptoms of a cerebrovascular disorder that in severe cases can lead to brain hemorrhage, a team of Yale researchers have found.
Welcome!
Our laboratory is interested in understanding the molecular mechanisms governing the development of the mammalian brain and how the perturbation of basic biological processes leads to clinically significant brain pathologies. Working closely with other research groups within the Yale Program on Neurogenetics, we study the molecular and cellular mechanisms underlying neurovascular and structural brain disorders associated with specific genetic lesions, aiming to gain insight into fundamental neurodevelopmental processes and to provide information relevant for the design of rational therapeutic approaches.
To learn more about our research activities, please see our Research section.
About Angeliki Louvi
Angeliki Louvi is an Associate Professor at Yale School of Medicine and a member of the Yale Program on Neurogenetics and the Interdepartmental Neuroscience Program. She obtained her PhD from the Department of Genetics and Development, Columbia P&S and did post-doctoral work at the Ecole Normale Supérieure and at the University of Chicago. She came to Yale in 2004.